Showing 1 - 15 results of 15 for search 'Lukas Käsmann', query time: 0.05s
Refine Results
-
1
Case report: Incidental MALT lymphoma of the left adrenal gland mimicking a metastatic spread within durvalumab maintenance treatment in inoperable stage III non-small cell lung ca... by Lukas Käsmann, Lukas Käsmann, Lukas Käsmann, Esra Degerli, Karim El-Marouk, Farkhad Manapov, Farkhad Manapov
Published 2024-03-01
Article -
2
-
3
-
4
-
5
-
6
-
7
Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment by Diego Kauffmann-Guerrero, Julian Taugner, Chukwuka Eze, Lukas Käsmann, Minglun Li, Amanda Tufman, Farkhad Manapov
Published 2021-10-01
Article -
8
Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World... by Julian Taugner, Lukas Käsmann, Chukwuka Eze, Amanda Tufman, Niels Reinmuth, Thomas Duell, Claus Belka, Farkhad Manapov
Published 2021-03-01
Article -
9
Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis by Monika Karin, Julian Taugner, Lukas Käsmann, Chukwuka Eze, Olarn Roengvoraphoj, Amanda Tufman, Claus Belka, Farkhad Manapov
Published 2020-10-01
Article -
10
PET/CT-based adaptive radiotherapy of locally advanced non-small cell lung cancer in multicenter yDEGRO ARO 2017-01 cohort study by Matthias Mäurer, Lukas Käsmann, Daniel F. Fleischmann, Michael Oertel, Danny Jazmati, Daniel Medenwald, Young DEGRO Trial Group
Published 2022-02-01
Article -
11
Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic... by Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Nina-Sophie Schmidt-Hegemann, Lukas Käsmann, Cherylina Wijaya, Claus Belka, Farkhad Manapov
Published 2019-09-01
Article -
12
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy by Lukas Käsmann, Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Maurice Dantes, Nina-Sophie Schmidt-Hegemann, Sanziana Schiopu, Claus Belka, Farkhad Manapov
Published 2020-07-01
Article -
13
Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: A pooled analysis of individual patient data from thr... by Tiantian Guo, Yue Zhou, Fei Liang, Zezhou Wang, Vincent Bourbonne, Lukas Käsmann, Nora Sundahl, Abraham Jing‐Ching Wu, Jianjiao Ni, Zhengfei Zhu
Published 2024-02-01
Article -
14
Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review by Lukas Käsmann, Alexander Dietrich, Claudia A. Staab-Weijnitz, Farkhad Manapov, Jürgen Behr, Andreas Rimner, Branislav Jeremic, Suresh Senan, Dirk De Ruysscher, Kirsten Lauber, Claus Belka
Published 2020-09-01
Article -
15
Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer by Georg W. Wurschi, Alexander Rühle, Justus Domschikowski, Maike Trommer, Simone Ferdinandus, Jan-Niklas Becker, Simon Boeke, Mathias Sonnhoff, Christoph A. Fink, Lukas Käsmann, Melanie Schneider, Elodie Bockelmann, David Krug, Nils H. Nicolay, Alexander Fabian, Klaus Pietschmann
Published 2024-03-01
Article